Literature DB >> 8478880

New classification of antirheumatic drugs. The evolution of a concept.

J P Edmonds1, D L Scott, D E Furst, H E Paulus.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8478880

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

Review 1.  Efficacy and toxicity of old and new disease modifying antirheumatic drugs.

Authors:  P Tugwell; V Welch; M Suarez-Almazor; B Shea; G Wells
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.

Authors:  B Bannwarth; F Péhourcq; T Schaeverbeke; J Dehais
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

3.  Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group.

Authors:  T Pham; D van der Heijde; A Calin; M A Khan; Sj van der Linden; N Bellamy; M Dougados
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 4.  Drug treatment of rheumatic diseases in the 1990s. Achievements and future developments.

Authors:  E H Choy; D L Scott
Journal:  Drugs       Date:  1997-03       Impact factor: 11.431

5.  A history of the term "DMARD".

Authors:  Jonas Kure Buer
Journal:  Inflammopharmacology       Date:  2015-05-23       Impact factor: 4.473
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.